Home » Topics » BioWorld Science, Cancer

BioWorld Science, Cancer
RSS

CH-7233163: an EGFR inhibitor active against osimertinib-resistant EGFR-T790M/C797S mutations

July 2, 2020

JS InnoPharm evaluates JSI-1187 for advanced solid tumors with MAPK pathway mutations

July 2, 2020

Corcept opens phase III study of relacorilant with nab-paclitaxel for metastatic pancreatic cancer

July 1, 2020

Exelixis initiates phase III CONTACT-02 study of cabozantinib plus atezolizumab in CRPC

July 1, 2020

New PI3K inhibitors identified at Innovent Biologics

July 1, 2020

Zanubrutinib demonstrates durable responses in patients with marginal zone lymphoma

July 1, 2020

Janssen presents preclinical data for first-in-class MALT1 inhibitor JNJ-6785663

June 30, 2020

Fibroblast growth factor receptor 4 inhibitors described by Guangdong Newopp Biopharmaceuticals

June 30, 2020

FDA grants IND allowance for phase Ia/b study of CG-806 in AML

June 30, 2020

Discovery of novel PRMT5 inhibitor, ALG-0700043

June 30, 2020

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 17, 2026.
Celia trial: data strong, analysts skeptical
BioWorld
Tuesday brought what was arguably the most anticipated presentation of the 2026 Alzheimer’s Association International Conference when Catherine Mummery, head of...
News in brief
BioWorld Asia
BioWorld Asia briefs for July 14, 2026
Voyager’s gene therapy reduces tau levels in AD models
BioWorld Science
At the Alzheimer’s Association International Conference, researchers from Voyager Therapeutics Inc. presented preclinical efficacy data for VY-1706, a blood-brain...
GABA signaling linked to immune resistance in some tumors
BioWorld
Certain cancers that contain organized clusters of immune cells known as tertiary lymphoid structures (TLS) do not respond to treatment as well as expected. Even...